| Trial | Intervention | No. participants | Median (h) | Range (h) | 95% CI | P‐value |
| Llanos‐Cuentas 2001 | Atovaquone‐proguanil | 14 | 57 | — | — | < 0.0001 |
| Chloroquine | 13 | 48 | — | — | — | |
| Borrmann 2003 | Atovaquone‐proguanil | 92 | 72 | 10 (IQR) | — | 0.0002 |
| Amodiaquine | 78 | 70 | 24 (IQR) | — | — | |
| Llanos‐Cuentas 2001 | Atovaquone‐proguanil | 5 | 42 | — | — | — |
| Sulfadoxine‐pyrimethamine | 7 | 42 | — | — | — | |
| Mulenga 1999 | Atovaquone‐proguanil | 81 | 72 | 12 to 102 | 12 to 24 | < 0.05 |
| Sulfadoxine‐pyrimethamine | 81 | 48 | 6 to 114 | — | — | |
| Anabwani 1999 | Atovaquone‐proguanil | 81 | 64.5 | 15 to 103 | — | — |
| Halofantrine | 83 | 50.4 | 17 to 78 | 11.5 to 20.8 | < 0.001 | |
| Looareesuwan 1999a | Atovaquone‐proguanil | 79 | 66.5 | 24 to 127 | — | < 0.05 |
| Mefloquine | 79 | 65.0 | 24 to 167 | — | — |